| P2093 | author name string | Baldini M | |
| | Boner AL | |
| | Pietrobelli A | |
| | Baldini G | |
| | Pifferi M | |
| | Marrazzini G | |
| | Ragazzo V | |
| P2860 | cites work | Asthma. From bronchoconstriction to airways inflammation and remodeling | Q33915771 |
| | A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force | Q34090755 |
| | Mushroom allergy | Q34171937 |
| | Does allergen immunotherapy alter the natural course of allergic disorders? | Q34212909 |
| | Specific immunotherapy in rhinitis and asthma. | Q34321324 |
| | A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function | Q36254831 |
| | Childhood asthma: application of the international view of management in Australia and New Zealand | Q37591533 |
| | Mucosal inflammation in asthma | Q37946348 |
| | Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma | Q39515670 |
| | Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study | Q39581669 |
| | Specific immunotherapy in asthma: is it effective? | Q40669499 |
| | The future for immunotherapy | Q41165375 |
| | Efficacy of specific immunotherapy in allergic asthma: myth or reality? | Q41573157 |
| | Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. | Q50621222 |
| | Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children | Q60684152 |
| | A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results | Q68876155 |
| | Standardization of spirometry--1987 update. Statement of the American Thoracic Society | Q69438135 |
| | Intrasubject between-day variability of PD20 methacholine assessed by the dosimeter inhalation test | Q69502646 |
| | Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma | Q70018361 |
| | Immunotherapy and allergic inflammation | Q70153934 |
| | Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy | Q70215225 |
| | Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes | Q70741308 |
| | Computed tomography of the lungs in asthma: influence of disease severity and etiology | Q70838878 |
| | Clinical effects of hyposensitization using a purified allergen preparation from Timothy pollen as compared to crude aqueous extracts from Timothy pollen and a four-grass pollen mixture respectively | Q72559469 |
| | Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses | Q72743177 |
| | Position paper: Immunotherapy | Q72860301 |
| | A controlled trial of immunotherapy for asthma in allergic children | Q73020915 |
| | Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study | Q73229297 |
| | Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity | Q73317967 |
| | Do asthmatic children benefit from specific immunotherapy? | Q74530477 |
| | Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients | Q74530506 |
| | Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment | Q93634271 |
| P433 | issue | 9 | |
| P921 | main subject | asthma | Q35869 |
| | immunotherapy | Q1427096 |
| | Dermatophagoides pteronyssinus | Q4573411 |
| P304 | page(s) | 785-790 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study | |
| P478 | volume | 57 | |